featured
ASCO 2015 Recap: Gastrointestinal Cancer—Part 1
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency [published online May 30, 2015]. N Engl J Med. DOI: 10.1056/NEJMoa1500596.
- Siena S, Sartore-Bianchi A, Lonardi S, et al. Trastuzumab and lapatinib in HER2-amplified metastatic colorectal cancer patients (mCRC): The HERACLES trial. Paper presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; May 29-June 2, 2015; Chicago, IL. Abstract 3508.
- Atreya CE, van Cutsem E, Bendell JC, et al. Updated efficacy of the MEK inhibitor trametinib, BRAF inhibitor dabrafenib, and anti-EGFR antibody panitumumab in patients with BRAF V600E mutated metastatic colorectal cancer. Paper presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; May 29-June 2, 2015; Chicago, IL. Abstract 103.
Disclosure statements are available on the authors' profiles: